| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
1 Department of Surgery, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei, 100, Taiwan
2 Angiogenesis Research Center, National Taiwan University, Taipei, Taiwan
3 Department of Applied Statistics and Information Science, Ming Chuan University, Taipei, Taiwan
4 Department of Computer Science, National Tsing Hua University, Hsing Chu, Taiwan
5 Department of Life Science, National Taiwan University, Taipei, Taiwan
6 Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan
7 Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
8 Department of Gynecology and Obstetrics, National Taiwan University Hospital, Taipei, Taiwan
Correspondence: Address correspondence and reprint requests to: Po-Huang Lee, MD, PhD; E-mail: pohuang{at}ha.mc.ntu.edu.tw
Background: Recurrence after hepatocellular carcinoma (HCC) resection is the major obstacle to improved survival. The presence of vascular invasion (VI) in pathology specimens is a well-known unfavorable prognostic factor for HCC recurrence. Though some VI-related genes have been reported, their association with recurrence-free survival is not known. We hypothesized that a gene expression profile for VI can predict the recurrence of HCC after liver resection.
Methods: Eighteen patients receiving complete HCC resection were included as a "training group". Genome-wide gene expression profile was obtained for each tumor using a microarray technique. Datasets were subjected to clustering analysis supervised by the presence or absence of VI to obtain 14 discriminative genes. We then applied those genes to execute pattern recognition using the k-Nearest Neighbor (KNN) classification method, and the best model for this VI gene signature to predict recurrence-free survival in the training group was obtained. The resulting model was then tested in an independent "test group" of 35 patients.
Results: A 14-gene profile was extracted which could accurately separate ten patients with VI and eight patients without VI in the "training group". In the "test group", significant difference in disease-free survival was found between patients predicted to have and not to have recurrence (P = .02823). In patients with stage_I disease, this model can also predict outcomes (P = .000205).
Conclusions: Using the 14-gene expression profile extracted from microarrays based on the presence of VI can effectively predict recurrence after HCC resection. This approach might facilitate "personalized medicine" for HCC patients after surgical resection.
Key Words: Hepatocellular carcinoma Microarray Gene expression Profiling Vascular invasion Liver resection Recurrence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |